PulsePoint has introduced HCP2DTC Influence™ , a new approach designed to better connect direct-to-consumer (DTC) campaigns with physician decision-making.
The launch addresses a longstanding structural challenge in pharma marketing: the disconnect between how brands engage healthcare professionals (HCPs) and how they target patients.
While significant investment has gone into understanding physician behavior—through sales teams, CRM systems, and HCP-targeted media—those insights have not always translated into consumer-facing strategies. As a result, patient demand generated through DTC campaigns does not always align with prescribing intent at the point of care.
Despite years of focus on aligning HCP and DTC strategies, pharma marketing still largely operates in silos. Brands build detailed views of physician behavior and prescribing patterns, while patient campaigns are often executed independently, focused on audience targeting and media reach. While there are signs of progress, both organisational structures and underlying technology have yet to fully support a truly connected approach.
PulsePoint’s HCP2DTC Influence aims to address this by starting with the HCP. The model combines first-party brand data with PulsePoint’s signals indicating physician readiness to prescribe, using this combined view to inform how and where patient audiences are targeted.
The objective is to better align patient demand with clinical...
Create your FREE account to continue reading and explore more expert insights on Pharma Media.
✅ Free. Fast. No commitment.